One worker died due to poisonous fumes at pharma unit

At Vijayasri Organics, an incident took place where one worker died and two others found critically injured because of inhaling poisonous fumes. Vijayasri Organics located in Jawaharlal Nehru Pharma City, Visakhapatnam in Andhra Pradesh. 

As per the reports, these poisonous fumes were leaked out from a drug manufacturing unit in the city’s Parwada area. The dead worker has been identified as Sridhar (32), and others are Chandrasekhar and Appa Rao. All were working inside a production block as operators in the unit and eventually poisonous gas leaked out.

Police said that Chandrasekhar and Appa Rao are currently on ventilator support and others were also treated but their condition is stable.KBS Prasad, deputy chief inspector of factories shared with the media that they investigated the unit when they got information about the incident and shared that they would initiate an internal inquiry into the matter soon.

The incident might have happened when they were adding a solvent to a reactor, which can lead to fumes. Centre of Indian Trade Unions (CITU) workers staged a protest and claimed company negligence as they did not give the necessary safety and protective gear to the workers.

CPI(M) members supported the protest and demanding strict action against the company management. Koteswara Rao, CITU leader asked ex-gratia for Rs 30 lakh for the deceased worker’s family. Workers also demanded the company to pay for the medical treatment of the other workers who were injured in the incident.

This is not the first incident that happened in that area. In 2017, when a cleaning operation was ongoing at Azico Biophore, two people were killed and several others injured when a reactor of a pharmaceutical unit exploded. This happened because a highly inflammable solvent was being used, to clean a new reactor.

Related Posts

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

New Delhi: The Centre has disclosed a significant enforcement action against hospitals found violating the guidelines of the Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), with 2,359 hospitals de-empanelled, 1,200…

NHS backs delayed‑release treatment for cystinosis

Decision expands options for eligible patients NHS England has recommended delayed‑release mercaptamine bitartrate for routine commissioning for eligible patients aged one year and above with nephropathic cystinosis. The decision provides…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

NHS backs delayed‑release treatment for cystinosis

NHS backs delayed‑release treatment for cystinosis

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry